Table 7.
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | P value | |
---|---|---|---|---|---|
Visual Diagnosis by Radiologist (VD) | |||||
N = 55 | N = 41 | N = 76 | N = 51 | ||
Bronchiectasis (%) | 45 | 31 | 57 | 62 | 0.018 |
Interstitial lung disease (ILD, %) | 25 | 34 | 30 | 10 | 0.030 |
Lung nodule (%) | 65 | 68 | 73 | 61 | 0.476 |
N = 14 | N = 14 | N = 23 | N = 5 | ||
Ground glass opacities (GGO) | 93% | 100% | 95% | 60% | 0.023 |
Reticular opacities | 93% | 93% | 100% | 80% | 0.309 |
Honeycombing | 57% | 29% | 65% | 40% | 0.163 |
Emphysema subtypes | |||||
N = 51 | N = 31 | N = 74 | N = 49 | ||
CLE | 7.8% | 16.1% | 10.8% | 6.1% | 0.481 |
PSE | 9.8% | 12.9% | 0 | 0 | < 0.005 |
PLE | 0 | 0 | 0 | 0 | NS |
CLE + PSE | 82.4% | 67.7% | 85.1% | 65.3% | < 0.005 |
CLE + PLE | 0 | 0 | 0 | 10.2% | < 0.005 |
PSE + PLE | 0 | 0 | 0 | 0 | NS |
CLE + PSE + PLE | 0 | 0 | 4.1% | 18.4% | < 0.0001 |
Progression Index | |||||
(ΔEmph% ≥ 1%) (Rapid-progressors) | N = 51 | N = 46 | N = 50 | N = 22 | |
25% | 11% | 58% | 68% | < 0.001 |
Kruskal-Wallis and chi-square tests were performed for continuous and categorical variables, respectively, and their P values were reported
Kruskal-Wallis and chi-square tests were performed for continuous and categorical variables, respectively. Five hundred ninety-nine SPIROMICS subjects were used for progression index (169 former smokers were available)
CLE Centrilobular, PSE Paraseptal, PLE Panlobular emphysema